surpass 1 tirzepatide Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial tirzepatide surpass versus insulin glargine

much of it is broken down before it can meaningfully raise intracellular antioxidant levels

it also improves cardiovascular health and increases muscle mass, which can boost the bodys metabolic rate

8a) and suffers from inhomogeneous cellular distribution 39

Clinical trial data from the SURMOUNT studies shows that roughly 4% to 5% of people taking tirzepatide report increased hair shedding, compared with just 1% in the placebo group

How much weight can I expect to lose on Ozempic or Mounjaro

When taking GLP-1s, it's important to combine them with lifestyle changes like a balanced diet, regular exercise and stress management, as weight is often connected to several aspects of your health